论文部分内容阅读
1.本文对采用不同用药方式的治疗浸潤型肺結核患者进行观察。按照統一标准选择的367例,按用药方式分为四組:即单用异菸肼組156例;鏈霉素+异菸肼粗99例;链霉素+对氨柳酸組13例;异菸肼+对氨柳酸組99例。各组又按过去曾否用过抗結核药物分为初治与复治。观察期中均采取一致步驟,按期作相互比較。 2.观察結果指出:单用与合併用药,病灶范围大小与临床疗效无明显差异。但过去曾否用过抗結核药物与疗效有密切关系。病程愈短,临床疗效愈高,系統治疗时間越长,疗效越明显。 3.对单独抑或合併应用抗結核药物,合併用药的方式及用药的期限等三个問题作了簡要的探討,并按本观察資料,对有关适应症提出建议。
1. This article uses different modes of treatment of patients with invasive pulmonary tuberculosis were observed. 367 cases were selected according to uniform standard and divided into four groups according to the way of treatment: 156 cases were treated with isoniazid alone; 99 cases were crude with streptomycin + isoniazid; 13 cases were treated with streptomycin plus salicylic acid; There were 99 cases of hydrazine + salicylic acid group. Each group is divided into first-time and retreatment according to whether past anti-TB drugs were used in the past. During the observation period, all agreed steps were taken and compared with each other on schedule. 2. Observation results show that: single and combined medication, the size of the lesion size and clinical efficacy no significant difference. However, whether anti-tuberculosis drugs have been used in the past is closely related to the efficacy. Shorter course, the higher the clinical efficacy, the longer the system treatment, the more obvious the effect. 3. On the alone or combined application of anti-TB drugs, the way of combining drugs and the duration of the drug and other three issues briefly discussed, and according to the observed data, the indications for the indications.